Bridgeway Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.84M | Buy |
121,900
+55,500
| +84% | +$1.75M | 0.09% | 304 |
|
|
2025
Q1 | $2.17M | Buy |
+66,400
| New | +$2.17M | 0.05% | 473 |
|
|
2019
Q2 | – | Sell |
-14,800
| Closed | -$519K | – | 1388 |
|
|
2019
Q1 | $519K | Hold |
14,800
| – | – | 0.01% | 1013 |
|
|
2018
Q4 | $492K | Hold |
14,800
| – | – | 0.01% | 1009 |
|
|
2018
Q3 | $745K | Hold |
14,800
| – | – | 0.01% | 1018 |
|
|
2018
Q2 | $886K | Hold |
14,800
| – | – | 0.01% | 915 |
|
|
2018
Q1 | $678K | Sell |
14,800
-700
| -5% | -$32.1K | 0.01% | 990 |
|
|
2017
Q4 | $618K | Buy |
15,500
+50
| +0.3% | +$1.99K | 0.01% | 1026 |
|
|
2017
Q3 | $618K | Sell |
15,450
-1,500
| -9% | -$60K | 0.01% | 1030 |
|
|
2017
Q2 | $731K | Buy |
16,950
+50
| +0.3% | +$2.16K | 0.01% | 957 |
|
|
2017
Q1 | $529K | Buy |
16,900
+5,800
| +52% | +$182K | 0.01% | 1054 |
|
|
2016
Q4 | $280K | Buy |
+11,100
| New | +$280K | ﹤0.01% | 1239 |
|
|
2015
Q2 | – | Sell |
-50,000
| Closed | -$605K | – | 1530 |
|
|
2015
Q1 | $605K | Hold |
50,000
| – | – | 0.01% | 1002 |
|
|
2014
Q4 | $415K | Sell |
50,000
-550
| -1% | -$4.57K | 0.01% | 1130 |
|
|
2014
Q3 | $439K | Buy |
50,550
+550
| +1% | +$4.78K | 0.01% | 1138 |
|
|
2014
Q2 | $548K | Hold |
50,000
| – | – | 0.01% | 1036 |
|
|
2014
Q1 | $447K | Hold |
50,000
| – | – | 0.01% | 1128 |
|
|
2013
Q4 | $377K | Hold |
50,000
| – | – | 0.01% | 1162 |
|
|
2013
Q3 | $367K | Hold |
50,000
| – | – | 0.01% | 1161 |
|
|
2013
Q2 | $322K | Buy |
+50,000
| New | +$322K | 0.01% | 1141 |
|